Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Guaifenesin

氢溴酸右美沙芬/盐酸伪麻黄碱/愈创甘油醚

Report date: 2022/04/02 09:42:42

Base Information

Drug NameDextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Guaifenesin
Drug Alias Name氢溴酸右美沙芬/盐酸伪麻黄碱/愈创木酚甘油醚美愈伪麻
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsAlpha adrenergic receptor agonists
TargetsGlutamate [NMDA] receptorAlpha adrenergic receptor
Therapy Area/IndicationsCommon Cold
Global Approved IndicationsCommon Cold
Approved Indications in ChinaCommon Cold
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryMainland China
CombinationsYes Dextromethorphan HydrobromidePseudoephedrine HydrochlorideGuaifenesin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNuode Pharmaceutical (Jiangsu) Co Ltd
Inactive CompaniesN/A
Active IndicationsCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeR05X
Related LinksN/A